221 related articles for article (PubMed ID: 27942931)
1. 3D modeling of keloid scars in vitro by cell and tissue engineering.
Suttho D; Mankhetkorn S; Binda D; Pazart L; Humbert P; Rolin G
Arch Dermatol Res; 2017 Jan; 309(1):55-62. PubMed ID: 27942931
[TBL] [Abstract][Full Text] [Related]
2. Reconstructed human keloid models show heterogeneity within keloid scars.
Limandjaja GC; van den Broek LJ; Waaijman T; Breetveld M; Monstrey S; Scheper RJ; Niessen FB; Gibbs S
Arch Dermatol Res; 2018 Dec; 310(10):815-826. PubMed ID: 30370495
[TBL] [Abstract][Full Text] [Related]
3. Deep and superficial keloid fibroblasts contribute differentially to tissue phenotype in a novel in vivo model of keloid scar.
Supp DM; Hahn JM; Glaser K; McFarland KL; Boyce ST
Plast Reconstr Surg; 2012 Jun; 129(6):1259-1271. PubMed ID: 22634643
[TBL] [Abstract][Full Text] [Related]
4. A wound contraction experimental model for studying keloids and wound-healing modulators.
Kamamoto F; Paggiaro AO; Rodas A; Herson MR; Mathor MB; Ferreira MC
Artif Organs; 2003 Aug; 27(8):701-5. PubMed ID: 12911344
[TBL] [Abstract][Full Text] [Related]
5. Asporin inhibits collagen matrix-mediated intercellular mechanocommunications between fibroblasts during keloid progression.
Liu L; Yu H; Long Y; You Z; Ogawa R; Du Y; Huang C
FASEB J; 2021 Jul; 35(7):e21705. PubMed ID: 34105826
[TBL] [Abstract][Full Text] [Related]
6. Establishment of an animal model for human keloid scars using tissue engineering method.
Wang H; Luo S
J Burn Care Res; 2013; 34(4):439-46. PubMed ID: 23222148
[TBL] [Abstract][Full Text] [Related]
7. Modeling aberrant wound healing using tissue-engineered skin constructs and multiphoton microscopy.
Torkian BA; Yeh AT; Engel R; Sun CH; Tromberg BJ; Wong BJ
Arch Facial Plast Surg; 2004; 6(3):180-7. PubMed ID: 15148128
[TBL] [Abstract][Full Text] [Related]
8. Keloids show regional distribution of proliferative and degenerate connective tissue elements.
Bux S; Madaree A
Cells Tissues Organs; 2010; 191(3):213-34. PubMed ID: 19641294
[TBL] [Abstract][Full Text] [Related]
9. Alterations in fibroblast alpha1beta1 integrin collagen receptor expression in keloids and hypertrophic scars.
Szulgit G; Rudolph R; Wandel A; Tenenhaus M; Panos R; Gardner H
J Invest Dermatol; 2002 Mar; 118(3):409-15. PubMed ID: 11874478
[TBL] [Abstract][Full Text] [Related]
10. Lysine acetylsalicylate decreases proliferation and extracellular matrix gene expression rate in keloid fibroblasts in vitro.
Petri JB; Haustein UF
Eur J Dermatol; 2002; 12(3):231-5. PubMed ID: 11978562
[TBL] [Abstract][Full Text] [Related]
11. Scanning electron microscopy of normal human scar tissue and keloids.
Hunter JA; Finlay JB
Br J Surg; 1976 Oct; 63(10):826-30. PubMed ID: 990706
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.
Dienus K; Bayat A; Gilmore BF; Seifert O
Arch Dermatol Res; 2010 Dec; 302(10):725-31. PubMed ID: 20872224
[TBL] [Abstract][Full Text] [Related]
13. Asiaticoside suppresses collagen expression and TGF-β/Smad signaling through inducing Smad7 and inhibiting TGF-βRI and TGF-βRII in keloid fibroblasts.
Tang B; Zhu B; Liang Y; Bi L; Hu Z; Chen B; Zhang K; Zhu J
Arch Dermatol Res; 2011 Oct; 303(8):563-72. PubMed ID: 21240513
[TBL] [Abstract][Full Text] [Related]
14. mTOR as a potential therapeutic target for treatment of keloids and excessive scars.
Ong CT; Khoo YT; Mukhopadhyay A; Do DV; Lim IJ; Aalami O; Phan TT
Exp Dermatol; 2007 May; 16(5):394-404. PubMed ID: 17437482
[TBL] [Abstract][Full Text] [Related]
15. Promoted activation of matrix metalloproteinase (MMP)-2 in keloid fibroblasts and increased expression of MMP-2 in collagen bundle regions: implications for mechanisms of keloid progression.
Imaizumi R; Akasaka Y; Inomata N; Okada E; Ito K; Ishikawa Y; Maruyama Y
Histopathology; 2009 May; 54(6):722-30. PubMed ID: 19438747
[TBL] [Abstract][Full Text] [Related]
16. Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis - Keloids and hypertrophic scars may be vascular disorders.
Ogawa R; Akaishi S
Med Hypotheses; 2016 Nov; 96():51-60. PubMed ID: 27959277
[TBL] [Abstract][Full Text] [Related]
17. Evidence of inter- and intra-keloid heterogeneity through analysis of dermal fibroblasts: A new insight in deciphering keloid physiopathology.
Serror K; Ferrero L; Boismal F; Sintes M; Thery M; Vianay B; Henry E; Gentien D; DE LA Grange P; Boccara D; Mimoun M; Bouaziz JD; Benssussan A; Michel L
Exp Dermatol; 2023 Jul; 32(7):1096-1107. PubMed ID: 37148203
[TBL] [Abstract][Full Text] [Related]
18. p53 and apoptosis alterations in keloids and keloid fibroblasts.
Ladin DA; Hou Z; Patel D; McPhail M; Olson JC; Saed GM; Fivenson DP
Wound Repair Regen; 1998; 6(1):28-37. PubMed ID: 9776848
[TBL] [Abstract][Full Text] [Related]
19. Adenoviral overexpression and small interfering RNA suppression demonstrate that plasminogen activator inhibitor-1 produces elevated collagen accumulation in normal and keloid fibroblasts.
Tuan TL; Hwu P; Ho W; Yiu P; Chang R; Wysocki A; Benya PD
Am J Pathol; 2008 Nov; 173(5):1311-25. PubMed ID: 18832570
[TBL] [Abstract][Full Text] [Related]
20. Green tea polyphenol epigallocatechin-3-gallate suppresses collagen production and proliferation in keloid fibroblasts via inhibition of the STAT3-signaling pathway.
Park G; Yoon BS; Moon JH; Kim B; Jun EK; Oh S; Kim H; Song HJ; Noh JY; Oh C; You S
J Invest Dermatol; 2008 Oct; 128(10):2429-41. PubMed ID: 18463684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
